Reply to Mammadov et al. Comment on “Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222”

Elisa Catanzaro; M. Gambato

doi:10.3390/jpm16010055

January 21, 2026Journal of Personalized MedicineOpen Access

Reply to Mammadov et al. Comment on “Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222”

View Full Paper

Ask AI

Bookmark

Share

Key Points

To address comments regarding risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.
Reviewed comments and findings from Mammadov et al.
Provided clarifications on previous analyses
Emphasized the importance of certain risk factors
Reinforced key risk factors identified in original study.
Clarified the clinical implications of recurrence rates.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Response addresses factors influencing primary sclerosing cholangitis recurrence post liver transplantation, suggesting implications for clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Catanzaro et al. (2026) studied this question.

synapsesocial.com/papers/69731005c8125b09b0d1fc33 https://doi.org/10.3390/jpm16010055

View Full Paper

Ask AI

Bookmark

Share

Reply to Mammadov et al. Comment on “Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222”

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Reply to Mammadov et al. Comment on “Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222”

Key Points

No abstract yet

Implication

Discussion

Cite This Study

Keep reading

Keep reading